Natixis Investment Managers International Regeneron Pharmaceuticals, Inc. Transaction History

Natixis Investment Managers International

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $352,589 - $475,074	-643 Reduced 19.2%	2,706 $1.6 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $1.99 Million - $2.34 Million	3,349 New	3,349 $2.34 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $1.28 Million - $1.54 Million	-3,815 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $587,106 - $683,028	1,672 Added 78.02%	3,815 $1.54 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $520,533 - $630,986	1,829 Added 582.48%	2,143 $739,000
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $99,167 - $123,646	314 New	314 $108,000
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $546,552 - $716,203	-1,524 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,524	1,524 $749,000

1,500

83M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

Stay updated on Natixis Investment Managers International with notifications on news.